Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Dotmatics Informatics Selected to Enhance Research at Moulder Center for Drug Discovery

Published: Friday, January 25, 2013
Last Updated: Friday, January 25, 2013
Bookmark and Share
The Dotmatics platform is an integrated suite of software specifically designed to maximise efficiency in data transfer between research institutes, collaborators and CROs.

"After a thorough review of the commercially available software packages for sharing and exploiting the fruits of drug discovery research, it became clear that the Dotmatics platform represented not only the best configuration, but also the most comprehensive package available" said Dr. Magid Abou-Gharbia, Associate Dean for Research and Director of the Moulder Center. "In building our capacity at the Moulder Center for Drug Discovery Research we are focused on efficiently generating research data using a host of technologies and tools. The combination of Browser, Vortex and StudiesNotebook are key solutions which will allow our scientists to quickly triage, integrate and analyze data from multiple sources, speeding the pace and efficiency of research. These advantages afford our scientists increased opportunity to improve the health of patients through the discovery of new therapeutic agents."

The migration of The Moulder Center for Drug Discovery Research's legacy database to the Dotmatics platform will have a positive and dramatic impact on research workflow. Dr. Abou-Gharbia continued “Researchers at our center will benefit from the advanced data querying, analysis and reporting tools provided by this high end informatics platform. In addition, the secure web-based deployment of Dotmatics software will allow our external collaborators to easily access their data while maintaining safeguards against the release of data from unrelated programs. Our adoption of the Dotmatics system provides The Moulder Center with cutting edge Cheminformatics and database capabilities.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos